Klaviyo, Inc. (KVYO)vsZepp Health Corp (ZEPP)
KVYO
Klaviyo, Inc.
$20.09
+1.01%
TECHNOLOGY · Cap: $6.08B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Klaviyo, Inc. generates 377% more annual revenue ($1.23B vs $258.90M). KVYO leads profitability with a -2.6% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
KVYO
Avoid30
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+48.2%
Fair Value
$39.27
Current Price
$20.09
$19.18 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Revenue surging 29.6% year-over-year
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Weak financial health signals
ROE of -2.9% — below average capital efficiency
Currently unprofitable
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : KVYO
The strongest argument for KVYO centers on Debt/Equity, Revenue Growth. Revenue growth of 29.6% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : KVYO
The primary concerns for KVYO are EPS Growth, Piotroski F-Score, Return on Equity.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
KVYO profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 30/100) and 43.0% revenue growth. KVYO offers better value entry with a 48.2% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Klaviyo, Inc.
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Klaviyo, Inc., a technology company that provides a software-as-a-service platform to enable its customers to send the right messages at the right time across email, short message service (SMS), and push notifications. The company is headquartered in Boston, Massachusetts.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?